162 related articles for article (PubMed ID: 34623468)
1. Medulloblastoma and esthesioneuroblastoma in a pediatric patient: a co-incidence or result of common genetic anomaly.
Sahoo SK; Madan R; Chatterjee D; Parkhi M; Kumar A
Childs Nerv Syst; 2022 May; 38(5):1023-1027. PubMed ID: 34623468
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Pediatric Medulloblastoma.
Jackson K; Packer RJ
Curr Neurol Neurosci Rep; 2023 Dec; 23(12):841-848. PubMed ID: 37943476
[TBL] [Abstract][Full Text] [Related]
3. [Pediatric esthesioneuroblastoma: an exceptional malignant lesion (a case study and literature review)].
Borni M; Kammoun B; Kolsi F; Boudawara MZ
Pan Afr Med J; 2018; 31():144. PubMed ID: 31037204
[TBL] [Abstract][Full Text] [Related]
4. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
[TBL] [Abstract][Full Text] [Related]
5. Aggressive esthesioneuroblastoma with divergent differentiation: A taxonomic dilemma.
Charles NC; Petris CK; Kim ET
Orbit; 2016 Dec; 35(6):357-359. PubMed ID: 27715372
[TBL] [Abstract][Full Text] [Related]
6. WNT-activated Pediatric Medulloblastoma Associated With Metastasis to the Suprasellar Region and Hypopituitarism.
Ahmad N; Eltawel M; Kashgari A; Alassiri AH
J Pediatr Hematol Oncol; 2021 May; 43(4):e512-e516. PubMed ID: 32815879
[TBL] [Abstract][Full Text] [Related]
7. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
Paul MR; Zage PE
Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
[No Abstract] [Full Text] [Related]
8. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
[TBL] [Abstract][Full Text] [Related]
9. Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension.
Yu Y; El-Sayed IH; McDermott MW; Theodosopoulos PV; van Zante A; Kased N; Glastonbury CM; Garsa AA; Yom SS
Laryngoscope; 2018 Oct; 128(10):2226-2233. PubMed ID: 29427378
[TBL] [Abstract][Full Text] [Related]
10. Esthesioneuroblastoma in children, adolescents and young adults.
Dumont B; Lemelle L; Cordero C; Couloigner V; Bernard S; Cardoen L; Brisse HJ; Jehanno N; Fréneaux P; Helfre S; Rouffiange L; Réguerre Y; Orbach D
Bull Cancer; 2020 Sep; 107(9):934-945. PubMed ID: 32896369
[TBL] [Abstract][Full Text] [Related]
11. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic-assisted excision of esthesioneuroblastoma.
Prasad KC; Kumar A; Prasad SC; Jain D
J Craniofac Surg; 2007 Sep; 18(5):1034-8. PubMed ID: 17912077
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
14. [Medulloblastoma. Pathology].
Siegfried A; Delisle MB
Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
[TBL] [Abstract][Full Text] [Related]
15. Aggressive large cell medulloblastoma extending to the extracranial region in brain-dead state.
Miwa T; Oi S; Nonaka Y; Tamogami R; Sasaki H; Yoshinari S; Ida H
Childs Nerv Syst; 2011 Aug; 27(8):1341-6. PubMed ID: 21533576
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
de Haas TG; Kool M
Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
18. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma with extensive nodularity (SHH medulloblastoma).
Fudyma IA; Wadhwani NR
Pol J Pathol; 2017; 68(4):364-366. PubMed ID: 29517209
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
Cambruzzi E
Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
